Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The model of BMI-loss efficacy demonstrated good performance in the self-report data, explaining 25% of the variance ( R 2 ) in both the training set and held out test set, with most of the variance explained by non-genetic factors (Supplementary Table 20)
A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv
10.3390/ijms19010011 Int
Cost and insurance coverage can either pave the way to a new treatment or present hurdles
Statistical analysis This systematic review and meta-analysis followed the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis ( PRISMA ) statement guidelines (Page et al
Because of this complexity, conventional analytical techniques are often not sensitive enough to fully characterize them
